Victor Levitsky

Company: Targovax

Job title: Chief Scientific Officer

Seminars:

Clinical Combination Strategies with Oncolytic Vaccines in Solid Tumours 3:30 pm

• Harnessing the clinical activity of oncolytic adenoviral vector ONCOS-102 in solid tumours of different origin • Identifying strong and consistent patterns of immuno-modulation with both PD1 blockade and chemotherapy • Utilising the selection of future combination strategies based on tumour biopsy translational dataRead more

day: Day Two